Brendan Teehan

Business address
C/O Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130
Top holdings (ownership)
PCRX and ACAD
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Brendan Teehan has filed 22 SEC EDGAR filings since 05 Nov 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 04 Feb 2025 01 Feb 2025 001-35060
3 Open Document Open Filing FORM 3 28 Jan 2025 21 Jan 2025 001-35060
4 Open Document Open Filing 19 Nov 2024 17 Nov 2024 000-50768
4 Open Document Open Filing 20 Aug 2024 16 Aug 2024 000-50768
4 Open Document Open Filing 03 May 2024 01 May 2024 000-50768
4 Open Document Open Filing 09 Apr 2024 05 Apr 2024 000-50768
4 Open Document Open Filing 27 Mar 2024 25 Mar 2024 000-50768
4 Open Document Open Filing 27 Feb 2024 23 Feb 2024 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 09 Jan 2024 06 Jan 2024 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 21 Nov 2023 17 Nov 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 19 May 2023 17 May 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 03 May 2023 01 May 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 02 May 2023 29 Apr 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 07 Apr 2023 05 Apr 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 27 Feb 2023 23 Feb 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 10 Jan 2023 06 Jan 2023 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 03 May 2022 29 Apr 2022 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 07 Apr 2022 05 Apr 2022 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 25 Feb 2022 23 Feb 2022 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 10 Jan 2022 06 Jan 2022 000-50768
4 Open Document Open Filing FORM 4 SUBMISSION 19 Nov 2021 17 Nov 2021 000-50768
3 Open Document Open Filing FORM 3 SUBMISSION 05 Nov 2021 01 Nov 2021 000-50768